Abpro Holdings, Inc. financial data

Symbol
ABP, ABPWW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6 St Johns Lane, Floor 5, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Atlantic Coastal Acquisition Corp. II (to 11/12/2024)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.3 % -33.2%
Debt-to-equity -108 % -125%
Return On Equity 4.9 %
Return On Assets -26 % -1161%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.2M shares
Common Stock, Shares, Outstanding 50.8M shares +165%
Entity Public Float 8.2M USD
Common Stock, Value, Issued 5K USD +150%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -9.92M USD +15.5%
Nonoperating Income (Expense) 2.69M USD +6623%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.23M USD +38.2%
Income Tax Expense (Benefit) 142K USD -91.3%
Net Income (Loss) Attributable to Parent -1.73M USD -140%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.85M USD +294%
Accounts Receivable, after Allowance for Credit Loss, Current 323K USD +267%
Assets, Current 3.78M USD +85.6%
Property, Plant and Equipment, Net 37K USD -63.7%
Operating Lease, Right-of-Use Asset 418K USD -56.7%
Assets 4.66M USD +38.9%
Accounts Payable, Current 3.94M USD -50.3%
Accrued Liabilities, Current 7.5M USD +39.3%
Liabilities, Current 19.6M USD +24.6%
Operating Lease, Liability, Noncurrent 455K USD
Liabilities 19.6M USD +21.1%
Retained Earnings (Accumulated Deficit) -116M USD -6.64%
Stockholders' Equity Attributable to Parent -15.5M USD +82.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -14.9M USD +83.1%
Liabilities and Equity 4.66M USD +38.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -264K USD -171%
Net Cash Provided by (Used in) Financing Activities -29.7M USD
Net Cash Provided by (Used in) Investing Activities 29.7M USD
Common Stock, Shares Authorized 110M shares +34.5%
Common Stock, Shares, Issued 51.8M shares +167%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -254K USD -161%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.99M USD +248%
Deferred Tax Assets, Valuation Allowance 33.3M USD +13.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 33.4M USD +12.5%
Operating Lease, Liability 456K USD
Lessee, Operating Lease, Liability, to be Paid 465K USD
Property, Plant and Equipment, Gross 2.69M USD 0%
Operating Lease, Liability, Current 456K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 465K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9K USD
Deferred Tax Assets, Operating Loss Carryforwards 23.2M USD +9.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Additional Paid in Capital 101M USD +405%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 113K USD -57%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%